← Back to Clinical Trials
Recruiting NCT05881863

To Investigate Airway Oxygen Concentrations During Rigid Bronchoscopy Procedures Performed With High Frequency Jet Ventilation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Central Airway Obstruction
Sponsor University of Minnesota
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-01-12
Completion 2026-12-31
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Thermal ablation (use of treatment modalities that generate heat) has become a widely used tool for treatment of central airway obstruction (e.g. laser, electrocautery, radiofrequency, and argon plasma coagulation). However, this method carries with it an increased risk for airway fire - a surgical fire that occurs in a patient's airway and could also include a fire in the attached breathing circuit. To decrease the risk of airway fire during mechanical ventilation with an endotracheal tube, the concentration of inspired oxygen (FiO2) is set below 40% while waiting for end tidal oxygen concentration (EtO2) to fall below 40% prior to starting thermal ablation. There is no published literature describing O2 concentration within the airways (AiO2) during jet ventilation with rigid bronchoscopy. The co-investigators of this study have recently collected data on AiO2 during rigid bronchoscopy using manual low frequency jet ventilation/high frequency jet ventilation with a period of apnea. The intent of this study is to measure the time taken for the central airway oxygen concentration to drop from 90 to 40% when the "laser mode" is activated on the Monsoon jet ventilator. Ventilation is continued during "laser mode."

Eligibility Criteria

Inclusion Criteria: * Patients undergoing rigid bronchoscopy for treatment of central airway obstruction at FV UMMC will be identified. * 18 years or older * Need rigid bronchoscopy as pre-determined by the interventional pulmonologist Exclusion Criteria: * Refusal to sign consent * Pregnant patients * Hemodynamic instability defined as continuous infusion of medication in order to support blood pressure and/or heart rate/rhythm * Respiratory instability defined as SpO2\<90% with \>90% supplemental oxygen. * Ineligible for rigid bronchoscopic intubation * Latex allergy * Evidence of fistulous airway * Active Bronchopleural fistula

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}